BD Acquires Tissuemed, Ltd. to Add Advanced Sealant to its Portfolio of Surgical Solutions

BD Acquires Tissuemed, Ltd. to Add Advanced Sealant to its Portfolio of Surgical Solutions

About the Engagement

Stenvall Skoeld & Company Limited (SSCO) provided valuation services and assessment of potential Chinese partners in combination with Tissuemed’s acquisition by BD.

Tissuemed is based in Leeds, UK. The company’s lead product, Tissuepatch™, is a proprietary sealant technology that bonds to tissue to help control internal bleeding or prevent leaks from surgical incisions. The technology’s thin, flexible and transparent composition that is ready to use out of the package makes it ideally suited for a range of surgical sealant applications.

Read more

About Stenvall Skoeld & Company

Stenvall Skoeld & Company (SSCO) is an M&A advisory firm with global reach on cross-border transactions. We act as financial advisors to buyers and sellers on mergers, acquisitions, divestitures, capital raises and other strategic and financial transactions and investment decisions. We specialize in cross-border transactions involving Asia, China in particular.

Monday August 29th, 2022